Geron reported $-18.43M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Amgen USD 1.33B 1.88B Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Exelixis USD 193.58M 8.73M Sep/2025
Genmab DKK 336M 141M Jun/2025
Geron USD -18.43M 2.05M Sep/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
MacroGenics USD 16.82M 53.07M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Novavax USD -121.3M 283.68M Sep/2024